By Hyun-woong Lee | San Diego(2026-06-27 14:38, The Munhwa Ilbo) “Global investors are no longer willing to invest based solely on the promise of platform technologies or their future potential.” Hyunchul Kim, President of the U.S. Office of the Korea Health Industry Development Institute (KHIDI), shared this assessment in an interview with Munhwa Ilbo during the BIO International Convention 2026, held this week in Boston. According to Kim, while global interest in Korean bio

Advanced Bio Innovation Hub to Serve as a Comprehensive Platform Connecting Industry, Academia, Research, and Healthcare By Sang-woo Roh | San Diego (2026-06-28 09:00, etoday) The Korea Health Industry Development Institute (KHIDI) is expanding its support system for Korean biotech companies beyond Boston to encompass the entire United States. Building upon its successful Boston model, KHIDI aims to evolve into a comprehensive platform that supports every stage of global mark

KHIDI Builds a Public-Private Partnership to Accelerate K-Bio’s Expansion into the U.S. Market Collaborating with KOTRA, Hallym University, SK Biopharmaceuticals, and the Korean American Society in Biotech and Pharmaceuticals (KASBP) As Korea’s biohealth exports continue to reach record highs, the Korea Health Industry Development Institute (KHIDI) is strengthening public-private partnerships to accelerate the successful entry of promising Korean biotech startups into the U.S

Building a Platform for Korea-Boston Innovation Ecosystem Collaboration The Korea-Boston Global Deep Tech Bridge Program 2026, jointly hosted by the Consulate General of the Republic of Korea in Boston and four Korean public institutions—KHIDI, KEIT, TIPA, and SNUH—was successfully held on May 21, 2026. The event attracted more than 500 venture capitalists, researchers, entrepreneurs, and industry leaders, providing a dynamic platform for collaboration between Korea’s innovat